JPRN-UMIN000005718已完成未知
Assessment of CXC chemokine receptor type 4 (CXCR4) expression as a predictive marker on the effect of leukocytapheresis for ulcerative colitis - Assessment of CXC chemokine receptor type 4 (CXCR4) expression as a predictive marker on the effect of leukocytapheresis for ulcerative colitis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with proctitis 2) Patients with either white blood cell count of less than 3,000/mm3, or hemoglobin level of less than 10g/dL, or platelet count of less than 100,000/mm3 3) Patients with fulminating active ulcerative colitis (massive bleeding, perforation, toxic megacolon) 4) Patients with serious infection or cardiovascular disease or liver disease or kidney disease or respiratory disease or metabolic disease neurologic disease 5) Patients with hypotension (less than maximal blood pressure 80mmHg) 6) Patients with allergic anamnesis or experience or the fear of allergic hypersensitivity reaction 7) Patients having received inhibitor of angiotensin converting enzyme 8) Patients who are pregnant or have the possibility of pregnancy 9) Patients who are younger than 12 years old or low weight 10) Patients determined to be inappropriate for this study by the investigators
研究者
相似试验
终止
1 期
A Study of LY2510924 and Durvalumab in Participants With Solid TumorsSolid TumorNCT02737072Eli Lilly and Company9
进行中（未招募）
1 期
CHEMOKINE RECEPTOR CXCR4-DIRECTED THERANOSTICS OF ADVANCED LYMPHOPROLIFERATIVE CANCERS BY RADIOPEPTIDE-BASED IMAGING AND THERAPY:THE COLPRIT PHASE I/II STUDYIndication: Non-Hodgkin lymphomas (NHL)Advanced lymphoproliferative cancers: aggressive B- and T- cell Non-Hodgkin lymphomas (NHL), including heavily pretreated transformed indolent lymphoma (tNHL) and multiple myeloma (MM) as a subgroup of B-cell NHLMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2022-002989-33-DEKlinikum rechts der Isar der Technischen Universität München38
进行中（未招募）
不适用
A study of the efficacy of POL6326 in treating patients following a heart attackMedDRA version: 18.0Level: LLTClassification code 10064345Term: ST segment elevation myocardial infarctionSystem Organ Class: 100000004849Acute Myocardial InfarctionEUCTR2012-003229-91-HUPolyphor AG140
进行中（未招募）
不适用
A study of the efficacy of POL6326 in treating patients following a heart attackAcute Myocardial InfarctionEUCTR2012-003229-91-DEPolyphor AG140
进行中（未招募）
不适用
A study of the efficacy of POL6326 in treating patients following a heart attackAcute Myocardial InfarctionEUCTR2012-003229-91-PLPolyphor AG140